Table 7.
TNF-α genotype and allele frequency for patients with GDM.
| TNF-α loci | Control group ( N = 280) | GDM group ( N = 160) | OR (95% CI) a | p a | ||
|---|---|---|---|---|---|---|
| n | Percentage (%) | n | Percentage (%) | |||
| −308 G/A | ||||||
| GG | 101 | 36.1 | 38 | 23.8 | 1.00REF | |
| GA | 114 | 40.7 | 79 | 49.4 | 1.84 (1.05-2.95) | 0.011 |
| AA | 65 | 23.2 | 43 | 26.8 | 1.76 (1.03-3.01) | 0.038 |
| G | 316 | 56.4 | 155 | 48.4 | 1.00REF | |
| A | 244 | 43.6 | 165 | 51.6 | 1.65 (1.25-2.17) | <0.001 |
| −863 C/A | ||||||
| CC | 152 | 54.3 | 90 | 56.3 | 1.00REF | |
| CA | 112 | 40.0 | 60 | 37.5 | 1.90 (0.51-1.61) | 0.847 |
| AA | 16 | 5.7 | 10 | 6.2 | 1.06 (0.33-3.42) | 0.832 |
| C | 416 | 74.3 | 240 | 75.0 | 1.00REF | |
| A | 144 | 25.7 | 80 | 25.0 | 1.96 (0.62-1.51) | 0.959 |
Note: The bolded data are significant in terms of statistics. “REF” represents “reference group.”
Abbreviations: CI, confidence interval; GDM, gestational diabetes mellitus; OR, odds ratio.
aAdjusted for sex and age by logistic regression model.